▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2302 by analyst upside · 2026-11-13
PACS
PACS Group, Inc.
Healthcare · Market Cap $8B · P/E 27.3x
ANALYST PRICE TARGET
+27.8%
implied upside to consensus target
Current Price $48.0
Consensus Target $61.33
Bull Target $67.0
Bear Target $57.0
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
4
Hold
0
Sell
0
52-Week Low $10.31
52-Week High $51.68
YTD Return +21.5%
FUNDAMENTALS
Market Cap $8B
P/E Ratio (TTM) 27.3x
Forward P/E 16.9x
EPS (TTM) $1.76
PEG Ratio 1.26
Dividend Yield N/A
Revenue (TTM) $5.7B
Profit Margin 4.9%
52-WEEK RANGE
52-Week Low $10.31
52-Week High $51.68
Current Price $48.0
Bear Target $57.0
Bull Target $67.0
● Now $48.0 ● Target $61.33
TRADING DATA
Avg Volume 794K
YTD Return +21.5%
Analyst Count 6
Consensus Buy
Upside to Target +27.8%
Last Updated 2026-11-13

ANALYST SUMMARY

PACS Group, Inc. (PACS) is currently trading at $48.0 with a Wall Street consensus price target of $61.33, implying potential upside of 27.8% over the next 12 months. 6 analysts currently cover PACS, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $67.0, while the most cautious has a target of $57.0.

PACS operates in the Healthcare sector with a market capitalisation of $8B. The stock is up 21.5% year-to-date and is currently trading near the upper end of its 52-week range of $10.31 – $51.68.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for PACS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS - Reiterated
Buy → Buy 2026-11-06 33% win rate (6 calls)
Truist Securities reit
Buy → Buy 2026-11-05 Building track record
Stephens & Co. - Reiterated
Overweight → Overweight 2026-11-05 Building track record
JP Morgan - Reiterated
Overweight → Overweight 2026-09-04 43% win rate (7 calls)
Oppenheimer - Reiterated
Outperform → Outperform 2026-08-10 14% win rate (7 calls)
UBS - Reiterated
Buy → Buy 2026-08-06 33% win rate (6 calls)
RBC Capital - Reiterated
Outperform → Outperform 2026-08-06 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-08-06 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
68
out of 100
Coverage depth
15/30
Consensus clarity
26/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →